Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Fluconazole-resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa.

Magobo RE, Lockhart SR, Govender NP; TRAC-South Africa group.

Mycoses. 2020 Mar 2. doi: 10.1111/myc.13070. [Epub ahead of print]

PMID:
32124485
2.

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.

Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG.

Clin Infect Dis. 2019 Dec 5. pii: ciz1008. doi: 10.1093/cid/ciz1008. [Epub ahead of print]

PMID:
31802125
3.

Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings.

Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, Chiller T.

J Fungi (Basel). 2019 Nov 28;5(4). pii: E111. doi: 10.3390/jof5040111. Review.

4.

Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.

Toda M, Williams SR, Berkow EL, Farley MM, Harrison LH, Bonner L, Marceaux KM, Hollick R, Zhang AY, Schaffner W, Lockhart SR, Jackson BR, Vallabhaneni S.

MMWR Surveill Summ. 2019 Sep 27;68(8):1-15. doi: 10.15585/mmwr.ss6808a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2019 Oct 18;68(41):934.

5.

In Vitro Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with FKS Mutations.

Nunnally NS, Etienne KA, Angulo D, Lockhart SR, Berkow EL.

Antimicrob Agents Chemother. 2019 Oct 22;63(11). pii: e01692-19. doi: 10.1128/AAC.01692-19. Print 2019 Nov.

PMID:
31481447
6.

Identification of Candida auris by Use of the Updated Vitek 2 Yeast Identification System, Version 8.01: a Multilaboratory Evaluation Study.

Ambaraghassi G, Dufresne PJ, Dufresne SF, Vallières É, Muñoz JF, Cuomo CA, Berkow EL, Lockhart SR, Luong ML.

J Clin Microbiol. 2019 Oct 23;57(11). pii: e00884-19. doi: 10.1128/JCM.00884-19. Print 2019 Nov.

PMID:
31413079
7.

The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection.

Singh S, Uppuluri P, Mamouei Z, Alqarihi A, Elhassan H, French S, Lockhart SR, Chiller T, Edwards JE Jr, Ibrahim AS.

PLoS Pathog. 2019 Aug 5;15(8):e1007460. doi: 10.1371/journal.ppat.1007460. eCollection 2019 Aug.

8.

Molecular typing of clinical and environmental isolates of Cryptococcus gattii species complex from southern California, United States.

Hurst S, Lysen C, Cooksey G, Vugia DJ, Litvintseva AP, Lockhart SR.

Mycoses. 2019 Nov;62(11):1029-1034. doi: 10.1111/myc.12980. Epub 2019 Aug 28.

PMID:
31376185
9.

A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare.

Hartnett KP, Jackson BR, Perkins KM, Glowicz J, Kerins JL, Black SR, Lockhart SR, Christensen BE, Beer KD.

J Fungi (Basel). 2019 Jul 24;5(3). pii: E69. doi: 10.3390/jof5030069. Review.

10.

On the Origins of a Species: What Might Explain the Rise of Candida auris?

Jackson BR, Chow N, Forsberg K, Litvintseva AP, Lockhart SR, Welsh R, Vallabhaneni S, Chiller T.

J Fungi (Basel). 2019 Jul 6;5(3). pii: E58. doi: 10.3390/jof5030058.

11.

Candida auris and multidrug resistance: Defining the new normal.

Lockhart SR.

Fungal Genet Biol. 2019 Oct;131:103243. doi: 10.1016/j.fgb.2019.103243. Epub 2019 Jun 20. Review.

PMID:
31228646
12.

Hospital-Associated Multicenter Outbreak of Emerging Fungus Candida auris, Colombia, 2016.

Armstrong PA, Rivera SM, Escandon P, Caceres DH, Chow N, Stuckey MJ, Díaz J, Gomez A, Vélez N, Espinosa-Bode A, Salcedo S, Marin A, Berrio I, Varón C, Guzman A, Pérez-Franco JE, Escobar JD, Villalobos N, Correa JM, Litvintseva AP, Lockhart SR, Fagan R, Chiller TM, Jackson B, Pacheco O.

Emerg Infect Dis. 2019 Jul;25(7). doi: 10.3201/eid2507.180491.

13.

Is This Zebra Really a Zebra? The Challenge of Diagnosing Rare Fungal Infections in Veterinary Pathology.

Lockhart SR, Gary JM.

Vet Pathol. 2019 Jul;56(4):510-511. doi: 10.1177/0300985819843684. No abstract available.

PMID:
31185881
14.

Candida auris: An Emerging Yeast Pathogen Posing Distinct Challenges for Laboratory Diagnostics, Treatment, and Infection Prevention.

Hata DJ, Humphries R, Lockhart SR; College of American Pathologists Microbiology Committee.

Arch Pathol Lab Med. 2020 Jan;144(1):107-114. doi: 10.5858/arpa.2018-0508-RA. Epub 2019 Jun 6.

PMID:
31169997
15.

Emerging and reemerging fungal infections.

Lockhart SR, Guarner J.

Semin Diagn Pathol. 2019 May;36(3):177-181. doi: 10.1053/j.semdp.2019.04.010. Epub 2019 Apr 17. Review.

PMID:
31010605
16.

Genotypes and population genetics of cryptococcus neoformans and cryptococcus gattii species complexes in Europe and the mediterranean area.

Cogliati M, Desnos-Ollivier M, McCormick-Smith I, Rickerts V, Ferreira-Paim K, Meyer W, Boekhout T, Hagen F, Theelen B, Inácio J, Alonso B, Colom MF, Trilles L, Montagna MT, De Donno A, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Trovato L, Dipineto L, Akcaglar S, Mlinaric-Missoni E, Bertout S, Vencá ACF, Sampaio AC, Criseo G, Ranque S, Çerikçioğlu N, Marchese A, Vezzulli L, Ilkit M, Pasquale V, Polacheck I, Lockhart SR.

Fungal Genet Biol. 2019 Aug;129:16-29. doi: 10.1016/j.fgb.2019.04.001. Epub 2019 Apr 3.

PMID:
30953839
17.

A high-throughput and rapid method for accurate identification of emerging multidrug-resistant Candida auris.

Ahmad A, Spencer JE, Lockhart SR, Singleton S, Petway DJ, Bagarozzi DA Jr, Herzegh OT.

Mycoses. 2019 Jun;62(6):513-518. doi: 10.1111/myc.12907. Epub 2019 Apr 4.

PMID:
30801778
18.

The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates In Vitro and In Vivo Activity against Candida auris.

Wiederhold NP, Lockhart SR, Najvar LK, Berkow EL, Jaramillo R, Olivo M, Garvey EP, Yates CM, Schotzinger RJ, Catano G, Patterson TF.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02233-18. doi: 10.1128/AAC.02233-18. Print 2019 Mar.

19.

Timing the Origin of Cryptococcus gattii sensu stricto, Southeastern United States.

Lockhart SR, Roe CC, Engelthaler DM.

Emerg Infect Dis. 2018 Nov;24(11):2095-2097. doi: 10.3201/eid2411.180975.

20.

Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey.

Chow NA, Gade L, Tsay SV, Forsberg K, Greenko JA, Southwick KL, Barrett PM, Kerins JL, Lockhart SR, Chiller TM, Litvintseva AP; US Candida auris Investigation Team.

Lancet Infect Dis. 2018 Dec;18(12):1377-1384. doi: 10.1016/S1473-3099(18)30597-8. Epub 2018 Oct 4.

21.

Multidrug-Resistant Aspergillus fumigatus Carrying Mutations Linked to Environmental Fungicide Exposure - Three States, 2010-2017.

Beer KD, Farnon EC, Jain S, Jamerson C, Lineberger S, Miller J, Berkow EL, Lockhart SR, Chiller T, Jackson BR.

MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1064-1067. doi: 10.15585/mmwr.mm6738a5.

22.

Activity of novel antifungal compound APX001A against a large collection of Candida auris.

Berkow EL, Lockhart SR.

J Antimicrob Chemother. 2018 Nov 1;73(11):3060-3062. doi: 10.1093/jac/dky302.

PMID:
30085167
23.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

24.

Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance.

Escandón P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, Rivera S, Misas E, Duarte C, Moulton-Meissner H, Welsh RM, Parra C, Pescador LA, Villalobos N, Salcedo S, Berrio I, Varón C, Espinosa-Bode A, Lockhart SR, Jackson BR, Litvintseva AP, Beltran M, Chiller TM.

Clin Infect Dis. 2019 Jan 1;68(1):15-21. doi: 10.1093/cid/ciy411.

PMID:
29788045
25.

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.

Revankar SG, Baddley JW, Chen SC, Kauffman CA, Slavin M, Vazquez JA, Seas C, Morris MI, Nguyen MH, Shoham S, Thompson GR 3rd, Alexander BD, Simkins J, Ostrosky-Zeichner L, Mullane K, Alangaden G, Andes DR, Cornely OA, Wahlers K, Lockhart SR, Pappas PG.

Open Forum Infect Dis. 2017 Sep 26;4(4):ofx200. doi: 10.1093/ofid/ofx200. eCollection 2017 Fall.

26.

Emerging Multidrug-Resistant Candida duobushaemulonii Infections in Panama Hospitals: Importance of Laboratory Surveillance and Accurate Identification.

Ramos R, Caceres DH, Perez M, Garcia N, Castillo W, Santiago E, Borace J, Lockhart SR, Berkow EL, Hayer L, Espinosa-Bode A, Moreno J, Jackson BR, Moran J, Chiller T, de Villarreal G, Sosa N; Red Nacional de Vigilancia Epidemiologica en Microbiologia Clinica, Vallabhaneni S.

J Clin Microbiol. 2018 Jun 25;56(7). pii: e00371-18. doi: 10.1128/JCM.00371-18. Print 2018 Jul.

27.

Notes from the Field: Surveillance for Candida auris - Colombia, September 2016-May 2017.

Escandón P, Cáceres DH, Espinosa-Bode A, Rivera S, Armstrong P, Vallabhaneni S, Berkow EL, Lockhart SR, Chiller T, Jackson BR, Duarte C.

MMWR Morb Mortal Wkly Rep. 2018 Apr 20;67(15):459-460. doi: 10.15585/mmwr.mm6715a6. No abstract available.

28.

Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.

Hashemi MM, Rovig J, Holden BS, Taylor MF, Weber S, Wilson J, Hilton B, Zaugg AL, Ellis SW, Yost CD, Finnegan PM, Kistler CK, Berkow EL, Deng S, Lockhart SR, Peterson M, Savage PB.

J Antimicrob Chemother. 2018 Jun 1;73(6):1537-1545. doi: 10.1093/jac/dky085.

PMID:
29635279
29.

Two cases of fungal keratitis caused by Metarhizium anisopliae.

Goodman AL, Lockhart SR, Lysen CB, Westblade LF, Burnham CD, Burd EM.

Med Mycol Case Rep. 2018 Mar 6;21:8-11. doi: 10.1016/j.mmcr.2018.03.003. eCollection 2018 Sep.

30.

Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway.

Vu K, Thompson GR 3rd, Roe CC, Sykes JE, Dreibe EM, Lockhart SR, Meyer W, Engelthaler DM, Gelli A.

Med Mycol. 2018 Oct 1;56(7):857-867. doi: 10.1093/mmy/myx135.

PMID:
29554336
31.

Triazole resistance surveillance in Aspergillus fumigatus.

Resendiz Sharpe A, Lagrou K, Meis JF, Chowdhary A, Lockhart SR, Verweij PE; ISHAM/ECMM Aspergillus Resistance Surveillance working group.

Med Mycol. 2018 Apr 1;56(suppl_1):83-92. doi: 10.1093/mmy/myx144. Review.

PMID:
29538741
32.

Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009-2015.

Benedict K, Roy M, Kabbani S, Anderson EJ, Farley MM, Harb S, Harrison LH, Bonner L, Wadu VL, Marceaux K, Hollick R, Beldavs ZG, Zhang AY, Schaffner W, Graber CR, Derado G, Chiller TM, Lockhart SR, Vallabhaneni S.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e78-e85. doi: 10.1093/jpids/piy009.

PMID:
29522195
33.

Saksenaea vasiformis Orbital Cellulitis in an Immunocompetent Child Treated With Posaconazole.

Reich P, Shute T, Lysen C, Lockhart SR, Kelly Keating M, Custer P, Orscheln R.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e169-e171. doi: 10.1093/jpids/piy021.

PMID:
29522137
34.

Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes.

McCarty TP, Lockhart SR, Moser SA, Whiddon J, Zurko J, Pham CD, Pappas PG.

J Antimicrob Chemother. 2018 Jun 1;73(6):1677-1680. doi: 10.1093/jac/dky059.

PMID:
29506044
35.

Candida auris for the clinical microbiology laboratory: Not your grandfather's Candida species.

Lockhart SR, Berkow EL, Chow N, Welsh RM.

Clin Microbiol Newsl. 2017 Jul 1;39(13):99-103. doi: 10.1016/j.clinmicnews.2017.06.003.

36.

Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates.

Reichert-Lima F, Lyra L, Pontes L, Moretti ML, Pham CD, Lockhart SR, Schreiber AZ.

Mycoses. 2018 Jun;61(6):360-365. doi: 10.1111/myc.12759. Epub 2018 Mar 23.

PMID:
29468746
37.

Detection of TR34/L98H CYP51A Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017.

Berkow EL, Nunnally NS, Bandea A, Kuykendall R, Beer K, Lockhart SR.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02240-17. doi: 10.1128/AAC.02240-17. Print 2018 May.

38.

Talaromycosis (Penicilliosis) in a Cynomolgus Macaque.

Iverson WO, Karanth S, Wilcox A, Pham CD, Lockhart SR, Nicholson SM.

Vet Pathol. 2018 Jul;55(4):591-594. doi: 10.1177/0300985818758468. Epub 2018 Feb 14.

PMID:
29444633
39.

Dating the Cryptococcus gattii Dispersal to the North American Pacific Northwest.

Roe CC, Bowers J, Oltean H, DeBess E, Dufresne PJ, McBurney S, Overy DP, Wanke B, Lysen C, Chiller T, Meyer W, Thompson GR 3rd, Lockhart SR, Hepp CM, Engelthaler DM.

mSphere. 2018 Jan 17;3(1). pii: e00499-17. doi: 10.1128/mSphere.00499-17. eCollection 2018 Jan-Feb.

40.

Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris.

Berkow EL, Lockhart SR.

Diagn Microbiol Infect Dis. 2018 Mar;90(3):196-197. doi: 10.1016/j.diagmicrobio.2017.10.021. Epub 2017 Nov 7.

PMID:
29307565
41.

Changes in the epidemiological landscape of invasive candidiasis.

Lamoth F, Lockhart SR, Berkow EL, Calandra T.

J Antimicrob Chemother. 2018 Jan 1;73(suppl_1):i4-i13. doi: 10.1093/jac/dkx444. Review.

PMID:
29304207
42.

Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States.

Walker TA, Lockhart SR, Beekmann SE, Polgreen PM, Santibanez S, Mody RK, Beer KD, Chiller TM, Jackson BR.

Emerg Infect Dis. 2018 Jan;24(1). doi: 10.3201/eid2401.170971.

43.

Diagnostic Importance of Hyphae on Heart Valve Tissue in Histoplasma Endocarditis and Treatment With Isavuconazole.

Wiley Z, Woodworth MH, Jacob JT, Lockhart SR, Rouphael NG, Gullett JC, Guarner J, Workowski K.

Open Forum Infect Dis. 2017 Nov 24;4(4):ofx241. doi: 10.1093/ofid/ofx241. eCollection 2017 Fall.

44.

Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology Clinic.

Vasquez A, Zavasky D, Chow NA, Gade L, Zlatanic E, Elkind S, Litvintseva AP, Pappas PG, Perfect JR, Revankar S, Lockhart SR, Chiller T, Ackelsberg J, Vallabhaneni S.

Clin Infect Dis. 2018 Mar 5;66(6):959-962. doi: 10.1093/cid/cix948.

PMID:
29121235
45.

Molecular characterization of Cryptococcus neoformans and Cryptococcus gattii from environmental sources and genetic comparison with clinical isolates in Apulia, Italy.

Montagna MT, De Donno A, Caggiano G, Serio F, De Giglio O, Bagordo F, D'Amicis R, Lockhart SR, Cogliati M.

Environ Res. 2018 Jan;160:347-352. doi: 10.1016/j.envres.2017.09.032. Epub 2017 Oct 17.

46.

Antifungal Susceptibility Testing Practices at Acute Care Hospitals Enrolled in the National Healthcare Safety Network, United States, 2011-2015.

Vallabhaneni S, Sapiano M, Weiner LM, Lockhart SR, Magill S.

Open Forum Infect Dis. 2017 Aug 16;4(4):ofx175. doi: 10.1093/ofid/ofx175. eCollection 2017 Fall.

47.

Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing.

Araúz AB, Caceres DH, Santiago E, Armstrong P, Arosemena S, Ramos C, Espinosa-Bode A, Borace J, Hayer L, Cedeño I, Jackson BR, Sosa N, Berkow EL, Lockhart SR, Rodriguez-French A, Chiller T.

Mycoses. 2018 Jan;61(1):44-47. doi: 10.1111/myc.12709. Epub 2017 Oct 16.

PMID:
28945325
48.

Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris.

Lockhart SR, Jackson BR, Vallabhaneni S, Ostrosky-Zeichner L, Pappas PG, Chiller T.

J Clin Microbiol. 2017 Dec;55(12):3324-3327. doi: 10.1128/JCM.01355-17. Epub 2017 Sep 13.

49.

Fluconazole resistance in Candida species: a current perspective.

Berkow EL, Lockhart SR.

Infect Drug Resist. 2017 Jul 31;10:237-245. doi: 10.2147/IDR.S118892. eCollection 2017. Review.

50.

Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.

Lepak AJ, Zhao M, Berkow EL, Lockhart SR, Andes DR.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00791-17. doi: 10.1128/AAC.00791-17. Print 2017 Aug.

Supplemental Content

Loading ...
Support Center